[Latest] Global Botulinum Toxin in Urology Market Size/Share Worth USD 1.98 Billion by 2035 at a 6.08% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
The global botulinum toxin in urology market is projected to grow from USD 1.1 billion in 2025 to USD 1.98 billion by 2035, at a CAGR of 6.08%. Growth is driven by increasing prevalence of urological disorders, aging populations, preference for minimally invasive treatments, and advancements in injection techniques. OnabotulinumtoxinA (Botox) leads the market, with overactive bladder being the largest application segment.
GRFSIPHAABSIAAPGMEDPOABINBTXCRDLMESOIMMPIMTXCLLSCGENABVXMXCTPLRZSGMOENLVCLGNBIAFBIAFWBNTXNBPEPRXGNTAINCYADAGISPCATHEMENSMSLEEVAXNRSNPBMNRCOABIWGMABONMDONMDWPHARPPBTRADXTLSA
Read the full story at GlobeNewswire Inc. ↗IntelliStock summarizes and links to the original publisher. Data delayed 15 minutes.